#CLEW MEDICAL STOCK SOFTWARE#

The salmon smolts will be monitored by the Marine Institute using a Slocum glider, an autonomous remotely operated vehicle. Their journey will be monitored through Clew Bay and Achill, onward along the shelf edge, west of Scotland and to the Norwegian feeding grounds from May to June. Studies have also indicated that smolts following ocean currents seem to travel the northern route past Clare Island.Īs part of the SeaMonitor project, the Marine Institute will be tagging smolts from the Burrishoole catchment over the next two years. This research will build on previous studies in the area, which indicate a high survival rate of salmon smolts through the Inner Bay and to Clare Island. Acoustic receivers will be placed in strategic positions on what has been identified as the salmon “highway” through Clew Bay. This new technology will be utilised in Clew Bay and Achill, to enable the Marine Institute to monitor juvenile salmon smolts as they make their first journey past Clare Island and on to the Atlantic Ocean. This technology will be used to better understand the movement and behaviour of species such as seals, basking shark, skate, cetaceans and salmon. The innovative technology, called passive acoustic telemetry, relies on underwater tracking stations (acoustic receivers) to monitor the movements of marine animals tagged with acoustic transmitters.

The project is funded by EU INTERREG VA Programme and led by the Loughs Agency and supported by another eight leading marine research institutions, including the Marine Institute.

Clew Bay and Achill, Co Mayo will be among the key study areas in SeaMonitor, a unique marine research project which is using innovative marine species tracking technology to better understand and protect vulnerable marine life in our oceans.

#CLEW MEDICAL STOCK SOFTWARE#

This software is designed to be used as a decision support tool and to be used with a patient’s clinical history, continuous monitoring data, diagnostic test results and clinical judgement.Ĭlew Medical said the system is not able to predict sudden deterioration, but rather analyzes trends in data that occur over time.Clew Bay and Achill key study areas in SeaMonitor marine research project. The system is cleared for use in adults in ICU while treating COVID-19 as a diagnostic aid with the early identification of patients who are likely to experience respiratory failure or hemodynamic instability. It uses commonly recorded vital signs, nursing assessments, flowsheet data, medications and lab data to compute patient status indexes.ĭata defined by the system includes CLEWRF, which is a measure of a patient’s predicted physiologic condition within the next eight hours based on the aggregate statistical risk of respiratory deterioration or failure, and CLEWHI, which is a measure of a patient’s predicted physiological condition within the next eight hours based on the aggregate statistical risk of hemodynamic instability. The system is a standalone software that is designated as a medical device.

The EUA covers the company’s ClewICUServer and ClewICUnitor. Clew Medical recently received FDA emergency use authorization for its ClewICU System for use in intensive care units.

Clew medical stock